摘要 |
The invention relates to new series of substituted quinoxalin 2,3-dions, new intermediate compounds, to methods for their preparation and to pharmaceutical compositons containing them. The compounds are used for the treatment of strokes, cerebral ischaemia or cerebral infarction produced from thromboembolia or haemorrhagic stroke,cerebral angiospasms, hypoglycaemia, stopping of the heart, epileptic conditions, perinatal asphyxia, anoxia and the Alzheimer, Parkingson and Huntingson diseases. 14 claims
|